Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: eico20 who wrote (1341)	6/24/2015 2:44:40 PM
From: oldcoach19	Read Replies (2) \| Respond to of 2026

David Collins got back to me a couple of minutes ago. I did not talk to him but he did leave a message saying Richard Pascoe is traveling and as yet has not touched base. He did say his [David} understanding was that Vitaros was sold for an average of 15 dollars per unit, the royalty rate was 10 to 15 percent, royalties averaged between 2:00-2:25, and sales were priced in dollars. He went on to say that there was no currency effect on our sales but the pricing would be more expensive on the cost of the product to the buyer and could have an effect on demand. If anyone would like to follow up with David the number is 1-212-924-9800.